AbbVie and Genmab Announce Positive Topline Results from Phase 1/2 EPCORE™ NHL-1 Trial Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Follicular Lymphoma (FL) ...Middle East

- Based on the topline results of epcoritamab from the EPCORE™ NHL-1 clinical trial, AbbVie and Genmab will engage global regulatory authorities to discuss next steps - Additional data from the clinical trial will be presented at a future medical meeting - Follicular lymphoma is a common...

Hence then, the article about abbvie and genmab announce positive topline results from phase 1 2 epcore nhl 1 trial evaluating epcoritamab duobody cd3xcd20 in patients with relapsed refractory follicular lymphoma fl was published today ( Wednesday 28/06/2023 - 02:01 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( AbbVie and Genmab Announce Positive Topline Results from Phase 1/2 EPCORE™ NHL-1 Trial Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Follicular Lymphoma (FL) )

Also on site :

• 'TV star Nick Owen recovering from second cancer scare - Midlands Today presenter reveals he has had surgery for disease in his kidney
• OpenAI to acquire the team behind executive coaching AI tool Convogo
• Gmail debuts a personalized AI Inbox, AI Overviews in search, and more